These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16941954)

  • 1. Systemic and mucosal antibody response in experimental Chlamydia pneumoniae infection of mice.
    Penttilä T; Wahlström E; Vuola JM; Sarvas M; Puolakkainen M
    Comp Med; 2006 Aug; 56(4):272-8. PubMed ID: 16941954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin A and CD8 T-cell mucosal immune defenses protect against intranasal infection with Chlamydia pneumoniae.
    Rodríguez A; Rottenberg M; Tjärnlund A; Fernández C
    Scand J Immunol; 2006 Mar; 63(3):177-83. PubMed ID: 16499570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
    Singh SR; Hulett K; Pillai SR; Dennis VA; Oh MK; Scissum-Gunn K
    Vaccine; 2006 Feb; 24(8):1213-24. PubMed ID: 16194585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease.
    Ciervo A; Visca P; Petrucca A; Biasucci LM; Maseri A; Cassone A
    Clin Diagn Lab Immunol; 2002 Jan; 9(1):66-74. PubMed ID: 11777831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model.
    Airaksinen U; Penttilä T; Wahlström E; Vuola JM; Puolakkainen M; Sarvas M
    Clin Diagn Lab Immunol; 2003 May; 10(3):367-75. PubMed ID: 12738633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant major outer membrane protein (MOMP) of Chlamydophila abortus, Chlamydophila pecorum, and Chlamydia suis as antigens to distinguish chlamydial species-specific antibodies in animal sera.
    Hoelzle LE; Hoelzle K; Wittenbrink MM
    Vet Microbiol; 2004 Oct; 103(1-2):85-90. PubMed ID: 15381270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia trachomatis serology: diagnostic value of outer membrane protein 2 compared with that of other antigens.
    Bas S; Muzzin P; Vischer TL
    J Clin Microbiol; 2001 Nov; 39(11):4082-5. PubMed ID: 11682533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of the recombinant protein MOMP(VD2-VD3) from Chlamydia pneumoniae in sero diagnosis].
    Zhou Z; Wu YM; Liu J; Chen CQ; Yang L
    Wei Sheng Wu Xue Bao; 2007 Jun; 47(3):512-6. PubMed ID: 17672316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice.
    Tammiruusu A; Haveri A; Pascolo S; Lahesmaa R; Stevanovic S; Rammensee HG; Sarvas M; Puolakkainen M; Vuola JM
    Scand J Immunol; 2005 Aug; 62(2):131-9. PubMed ID: 16101819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection.
    Murdin AD; Dunn P; Sodoyer R; Wang J; Caterini J; Brunham RC; Aujame L; Oomen R
    J Infect Dis; 2000 Jun; 181 Suppl 3():S544-51. PubMed ID: 10839756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an in vivo CD4+ T cell-mediated response to polymorphic membrane proteins of Chlamydia pneumoniae during experimental infection.
    Mygind T; Vandahl B; Pedersen AS; Christiansen G; Höllsberg P; Birkelund S
    FEMS Immunol Med Microbiol; 2004 Mar; 40(2):129-37. PubMed ID: 14987731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants.
    Wolf K; Fischer E; Mead D; Zhong G; Peeling R; Whitmire B; Caldwell HD
    Infect Immun; 2001 May; 69(5):3082-91. PubMed ID: 11292727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to the 60-kDa heat-shock protein of Chlamydia pneumoniae in patients with coronary artery disease.
    Jantos CA; Krombach C; Wuppermann FN; Gardemann A; Bepler S; Asslan H; Hegemann JH; Haberbosch W
    J Infect Dis; 2000 May; 181(5):1700-5. PubMed ID: 10823771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High sensitivity C-reactive protein and immunoglobulin G against Chlamydia pneumoniae and chlamydial heat shock protein-60 in ischemic heart disease.
    Jafarzadeh A; Esmaeeli-Nadimi A; Shariati M
    Iran J Immunol; 2008 Mar; 5(1):51-6. PubMed ID: 18319525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB.
    Barker CJ; Beagley KW; Hafner LM; Timms P
    Vaccine; 2008 Mar; 26(10):1285-96. PubMed ID: 18261829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heat shock protein antibodies and other chlamydial antigens in various diseases and their occurrence in blood donors].
    Pospísil L; Canderle J; Stroblová H; Zeman K; Medková Z
    Cas Lek Cesk; 2003; 142(11):661-4. PubMed ID: 14689825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
    Hickey DK; Aldwell FE; Beagley KW
    Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Chlamydia pneumoniae-specific antibodies binding to the VD2 and VD3 regions of the major outer membrane protein.
    Klein M; Kötz A; Bernardo K; Krönke M
    J Clin Microbiol; 2003 May; 41(5):1957-62. PubMed ID: 12734234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental infection of Chlamydia pneumoniae in mice.
    Kaukoranta-Tolvanen SS; Laurila AL; Saikku P; Leinonen M; Liesirova L; Laitinen K
    Microb Pathog; 1993 Oct; 15(4):293-302. PubMed ID: 8309355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model.
    Penttilä T; Tammiruusu A; Liljeström P; Sarvas M; Mäkelä PH; Vuola JM; Puolakkainen M
    Vaccine; 2004 Sep; 22(25-26):3386-94. PubMed ID: 15308363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.